These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1677774

  • 1. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
    Diamond BI, Nguyen H, O'Neal E, Ochs R, Kaffeman M, Borison RL.
    Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
    [Abstract] [Full Text] [Related]

  • 2. Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients.
    Minervini MG, Priore P, Farolfi A, Cesana B, Morselli PL.
    Pharmacopsychiatry; 1990 Mar; 23(2):102-6. PubMed ID: 1971117
    [Abstract] [Full Text] [Related]

  • 3. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S, Lader M.
    Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 5. Studies with alpidem in normal volunteers and anxious patients.
    Morton S, Lader M.
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():120-3. PubMed ID: 1974071
    [Abstract] [Full Text] [Related]

  • 6. [Double-blind versus placebo comparison of single dose alpidem (50 mg or 75 mg) in a model of situational anxiety].
    Regnier F, Chastel A, L'Heritier C, Magni G, Henry M.
    Therapie; 1989 May; 44(4):279-83. PubMed ID: 2574502
    [Abstract] [Full Text] [Related]

  • 7. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK.
    Psychopharmacol Bull; 1993 May; 29(2):303-8. PubMed ID: 7904761
    [Abstract] [Full Text] [Related]

  • 8. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [Abstract] [Full Text] [Related]

  • 9. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 10. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I, Colombo G, Furlanut M, Benetello P.
    Int J Clin Pharmacol Res; 1989 Dec; 9(3):203-8. PubMed ID: 2568350
    [Abstract] [Full Text] [Related]

  • 11. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
    Bassi S, Albizzati MG, Ferrarese C, Frattola L, Cesana B, Piolti R, Farolfi A.
    Clin Neuropharmacol; 1989 Feb; 12(1):67-74. PubMed ID: 2565767
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Feb; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 13. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL, Parmley LF.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC, O'Hair DE.
    Clin Ther; 1980 Oct; 3(3):209-18. PubMed ID: 6109568
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern ME, Micallef J, Blin O.
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [Abstract] [Full Text] [Related]

  • 16. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP.
    Encephale; 1995 Oct; 21(6):459-66. PubMed ID: 8674471
    [Abstract] [Full Text] [Related]

  • 18. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [Abstract] [Full Text] [Related]

  • 19. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [Abstract] [Full Text] [Related]

  • 20. Alpidem in the treatment of panic disorder.
    Schneier FR, Carrasco JL, Hollander E, Campeas R, Fallon B, Saoud JB, Feerick J, Liebowitz MR.
    J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.